INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For Respiratory Papillomatosis

RTTNews | vor 929 Tagen
INOVIO Reports Positive Interim Phase 1/2 Trial Results For INO-3107 For  Respiratory Papillomatosis

(RTTNews) - Biotechnology company Inovio Pharmaceuticals Inc. (INO) announced Thursday positive interim results from an ongoing Phase 1/2 clinical trial evaluating INO-3107 for the treatment of HPV 6 and HPV 11-associated Recurrent Respiratory Papillomatosis (RRP) in adults.

In the first cohort of 21 participants, INO-3107 showed a statistically significant improvement in the clinical endpoint of the number of surgical interventions needed to control papilloma growth.

INO-3107 was also observed to be well-tolerated and immunogenic in the trial. INO-3107 received Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in July 2020.

INO-3107 was evaluated in a Phase 1/2 open-label, multicenter trial to assess its safety, tolerability, immunogenicity, and efficacy in 32 participants with HPV 6 and/or HPV 11-associated RRP.

Results from the second cohort of 11 patients are expected in the first half of 2023.

For More Such Health News, visit rttnews.com

read more
Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Inovio Pharma Receives FDA Feedback On Submission Of BLA For INO-3107 To Treat RRP

Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that data from its completed Phase 1/2 trial of INO-3107 for the treatment of RRP could support INOVIO's submission of a BLA for review under the FDA's accelerated approval program.
RTTNews | vor 567 Tagen
French Economy Recovers In Q1

French Economy Recovers In Q1

The French economy avoided a technical recession in the first quarter with a marginal expansion, official data revealed on Wednesday. Gross domestic product grew 0.1 percent from the fourth quarter, when the economy shrank 0.1 percent, flash data from the statistical office INSEE revealed. The rate came in line with expectations.
RTTNews | vor 1Std 14 Minuten
Sensex, Nifty Marginally Higher In Lackluster Trade

Sensex, Nifty Marginally Higher In Lackluster Trade

Indian shares struggled for director on Wednesday as investors watched the latest developments on the trade front and awaited key U.S. inflation data for additional clues on the Fed's rate trajectory.
RTTNews | vor 2Std 50 Minuten
Australian Market Trims Early Gains In Mid-market

Australian Market Trims Early Gains In Mid-market

The Australian stock market is trimming its early gains in mid-market moves on Wednesday, adding to the gains in the previous four sessions, with the benchmark S&P/ASX 200 moving up to near the 8,100 level, following the broadly positive cues from Wall Street overnight, with gains financial and technology stocks partially offset by weakness in energy stocks.
RTTNews | vor 3Std 43 Minuten